Mylan's Aflibercept Biosimilar Gets Green Light For Trials In India

 
• By Anju Ghangurde
Green
Mylan's Biosimlar Rival To Eylea Gets Go Ahead For Phase III • Source: Shutterstock

More from Biosimilars

More from Products